In light of the ongoing COVID-19 pandemic, the U.S. Bankruptcy Court for the Southern District of New York has granted a 30-day extension of the deadline to file a claim against Purdue Pharma L.P.,1 including claims related to Purdue prescription opioids, like Ox...
or take action regarding suspected illegal activities, suspected fraud, the rights, reputation, safety, and property of us, users or others, or violations of our policies or other agreements with us; respond to claims and legal process (e.g., subpoenas); and/or protect against legal liability...
addition, McKinsey U.S. has agreed to settle a related civil False Claims Act investigation and to enter into a Corporate Integrity Agreement with the Office of Inspector General at the Department of Health and Human Services. Under the terms of the deferred prosecution agreement, McKinsey will:...
A unit of French advertising giant Publicis Groupe SA agreed Thursday to pay $350 million to settle claims it helped OxyContin maker Purdue Pharma fuel the opioid epidemic in the United States. State attorneys general claimed Publicis Health played an integral role in developing "predatory and...
Purdue Pharma, Sacklers Reach $7.4B National Opioid Settlement January 24, 2025 Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction crisis in the U....
Jones Day successfully represented Purdue Pharma L.P. in related Hatch-Waxman patent infringement actions against defendant Ascent Pharmaceuticals, Inc., pertaining to the submission of an Abbreviated New Drug Application to the FDA seeking approval of a
A unit of French advertising giant Publicis Groupe SA agreed Thursday to pay $350 million to settle claims it helped OxyContin maker Purdue Pharma fuel theopioid epidemicin the United States. State attorneys general claimed Publicis Health played an integral role...
A unit of French advertising giant Publicis Groupe SA agreed Thursday to pay $350 million to settle claims it helped OxyContin maker Purdue Pharma fuel theopioid epidemicin the United States. State attorneys general claimed Publicis Health played an integral role in deve...
Purdue Pharma L.P. Primary Class: 1/1 Other Classes: 707/999.102, 707/E17.005 International Classes: G06F17/30;G06F7/00 View Patent Images: Download PDF 20080281858 Attorney, Agent or Firm: Leason Ellis LLP Claims: We claim: 1.A computer-assisted method for electronically creating an itine...
et al. Pharmazuetische Technologie, (1986) pp. 362-365. Bigelow GE. Forward. In: Cowan A, Lewis JW, eds. Buprenorphine: Combating Drug Abuse With a Unique Opioid. New York, NY: Wiley-Liss: 1995:xi-xiii. Bliesener N, et al., Plasma Testosterone and Sexual Function in Men ...